Inventor · disambiguated record
Samuel K. Ackerman
Also filed as: ACKERMAN SAMUEL · ACKERMAN SAMUEL K
14 granted patents·7 pending applications·230 citations·filing 1997–2004
93Inventor score
Files withVI TECHNOLOGIES INC12PENTOSE PHARMACEUTICALS INC2CYCLIS PHARMACEUTICALS INC1ORAVAX MERIEUX CO1
Top patents by PatentIndex Score
21 records- 0183US5891705AMethod for inactivating a virusPENTOSE PHARMACEUTICALS INC·Filed 1997·Granted Apr 6, 1999·67 cites·8 claims
- 0281US6093564AMethods and compositions for the selective modification of nucleic acidsVI TECHNOLOGIES INC·Filed 1998·Granted Jul 25, 2000·42 cites·18 claims
- 0367US6403359B1Solid phase quenching systemsVI TECHNOLOGIES INC·Filed 1998·Granted Jun 11, 2002·13 cites·29 claims
- 0459US2004053316A1Methods and compositions for the selective modification of nucleic acidsVI TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 0555US6617157B1Methods and compositions for the selective modification of nucleic acidsVI TECHNOLOGIES INC·Filed 1998·Granted Sep 9, 2003·10 cites·4 claims
- 0655US6369048B1Methods and compositions for inactivating virusesVI TECHNOLOGIES INC·Filed 1998·Granted Apr 9, 2002·38 cites·41 claims
- 0755US6150109ALipophilic quenching of viral inactivating agentsVI TECHNOLOGIES INC·Filed 1999·Granted Nov 21, 2000·14 cites·10 claims
- 0854US6617101B1Lipophilic quenching of viral inactivating agentsVI TECHNOLOGIES INC·Filed 2000·Granted Sep 9, 2003·0 cites·14 claims
- 0953US6720136B2Solid phase quenching systemsVI TECHNOLOGIES INC·Filed 2002·Granted Apr 13, 2004·0 cites·7 claims
- 1051US5837240AMultimeric, recombinant urease vaccineORAVAX MERIEUX CO·Filed 1997·Granted Nov 17, 1998·15 cites·10 claims
- 1149US2003202986A1Methods and compositions for the selective modification of nucleicFiled 2003·Application pending·0 cites
- 1248US2004048235A1Methods and compositions for the selective modification of nucleic acidsVI TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 1346US6468991B1Method of treating rhinoviral infectionsCYCLIS PHARMACEUTICALS INC·Filed 1997·Granted Oct 22, 2002·8 cites·20 claims
- 1444US2004266857A1Novel lapachone compounds and methods of use thereofFiled 2004·Application pending·0 cites
- 1542US2002034724A1Methods to selectively inactivate microorganisms in biological compositionsFiled 2001·Application pending·0 cites
- 1640US5955446AMethod of treating herpes infections with 2',5'-oligoadenylate-2',3'-cyclophosphate compoundsPENTOSE PHARMACEUTICALS INC·Filed 1997·Granted Sep 21, 1999·6 cites·6 claims
- 1738US2002123480A1Methods and compositions utilizing 2'-5' oligoadenylates in the treatment of disorders of cell proliferationFiled 2001·Application pending·0 cites
- 1835US6352695B1Methods and compositions for the selective modification of nucleic acidsVI TECHNOLOGIES INC·Filed 1997·Granted Mar 5, 2002·9 cites·15 claims
- 1934US2003149011A1Methods and reagents for extracorporeal immunomodulatory therapyFiled 2001·Application pending·0 cites
- 2030US6617100B2Solid phase quenching systemsVI TECHNOLOGIES INC·Filed 1999·Granted Sep 9, 2003·8 cites·19 claims
- 2128US6774123B1Methods and compositions for inactivating virusesVI TECHNOLOGIES INC·Filed 1999·Granted Aug 10, 2004·0 cites·33 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →